Previous Article | Next Article ![]()
J Virol, July 1998, p. 5735-5744, Vol. 72, No. 7
Department of Biochemistry and Kaplan
Comprehensive Cancer Center, New York University Medical Center,
New York, New York 10016
Received 4 December 1997/Accepted 31 March 1998
The modulation of DNA replication by transcription factors was
examined by using bovine papillomavirus type 1 (BPV). BPV replication in vivo requires two viral proteins: E1, an origin-binding protein, and
E2, a transcriptional transactivator. In the origin, E1 interacts with
a central region flanked by two binding sites for E2 (BS11 and BS12),
of which only BS12 has been reported to be essential for replication in
vivo. Using chemical interference and electrophoretic mobility shift
assays, we found that the binding of E2 to each site stimulates the
formation of distinct E1-origin complexes. A high-mobility C1 complex
is formed by using critical E2 contacts to BS12 and E1 contacts to the
dyad symmetry element. In contrast, interaction of E2 with the BS11
element on the other origin flank promotes the formation of the
lower-mobility C3 complex. C3 is a novel species that resembles C2, a
previously identified complex that is replication active and formed by
E1 alone. The binding of E1 greatly differs in the C1 and C3 complexes,
with E1 in the C1 complex limited to the origin dyad symmetry region
and E1 in the C3 complex encompassing the region from the proximal edge of BS11 through the distal edge of BS12. We found that the presence of
both E2-binding sites is necessary for wild-type replication activity
in vivo, as well as for maximal production of the C3 complex. These
results show that in the normal viral context, BS11 and BS12 play
separate but synergetic roles in the initiation of viral DNA
replication that are dependent on their location within the origin. Our
data suggest a model in which the binding of E2 to each site
sequentially stimulates the formation of distinct E1-origin complexes,
leading to the replication-competent complex.
Transcription factors have recently
been recognized to play important modulatory roles during the
initiation of eukaryotic DNA replication. In most cases, these factors
act not by regulating neighboring transcription units but, rather, by
directly interacting with proteins bound to an origin of replication or
with the DNA itself (43). The mechanisms by which
transcription factors regulate DNA replication have been most clearly
defined by using viral systems such as bovine papillomavirus (BPV)
(29), adenovirus (19, 30), and simian virus 40 (SV40) (7), although chromosomal examples exist as well
(see, e.g., reference 11). In these systems, transcription factors act through various means, including the recruitment of replication proteins to the origin, the modulation of
the activity of bound replication proteins, and the disruption of the
local nucleosome structure, allowing replication factors access to the
DNA.
In the BPV model system, in vivo replication of DNA containing the BPV
origin requires two viral proteins designated E1 and E2
(41), although only E1 is essential in vitro (36,
45). E1 is a DNA helicase (36, 46) and DNA-binding
protein (29) that recognizes a dyad symmetry element within
the viral origin of replication (16, 42, 45). Origin binding
by E1 is cooperative with E2 (24, 32, 37, 45), and this
cooperativity is mediated by physical interaction between E1 and E2
(1-3, 22, 29). In the presence of a
single-stranded-DNA-binding protein such as human replication protein A
(hRPA), E1 unwinds the DNA outward from the origin, with its DNA
helicase functioning in the 3' The region encompassing the origin contains a dyad symmetry element
adjacent to an AT-rich domain. This central region is flanked by two
binding sites for E2 termed BS11 and BS12, adjacent to the AT-rich and
dyad elements, respectively. Mutational analysis to determine the
minimal origin sequence has indicated that the central region and BS12
are required for replication in vivo (42). Consistent with
the need only for E1 to support replication in vitro, a smaller region
lacking most of BS12 can suffice when cell-free systems are used
(20). The two viral proteins form various complexes over the
origin region as detected by electrophoretic mobility shift assays. E1
in the absence of E2 forms a relatively slowly migrating complex (C2 in
the terminology of reference 23), using critical
contacts within the dyad element (16, 17, 23, 34). The
binding of E1 causes the ATP-dependent induction of structural changes
to the viral origin (13). On an origin containing the
central region and BS12, the addition of E2 to E1 can give rise to two
distinct complexes: a fast-migrating complex containing a lower
oligomeric form of E1 (C1 in the terminology of reference 23; a similar complex was observed by the Stenlund
laboratory [32, 33]), and an apparent C2 complex
(lacking E2 [23, 32-34]). By using an origin that
contained both E2-binding sites, it was shown that an increase in the
ratio of E1 to E2 caused an extension of the E1 footprint from the dyad
region into the AT-rich region and stimulated distortion of the origin
(13). The C1 and C2 complexes have different functional
properties; the C2 complex is competent for replication, while C1 is
inactive (23; see also reference
34).
We have used chemical interference and transient-replication assays to
examine the role of E2 and E2-binding sites in viral replication. We
find that each flanking E2-binding site plays distinct and important
roles during the initiation of BPV DNA replication. E2 binding to BS12
serves to recruit E1 to the origin. In contrast, the interaction of E2
with BS11 stabilizes the binding of E1 across the central origin and
BS12 regions, yielding a novel complex that we term C3. We propose that
in this final initiation complex, E1 recognizes the origin in a
structure similar to that formed by the SV40 T antigen on its cognate
origin, using the central palindromic element to produce a complex with
twofold dyad symmetry encompassing the AT-rich, dyad, and BS12 regions.
E1 and E2 proteins.
The GST-E1 (4) and E2
(22) proteins were overexpressed in Sf9 insect cells by
using recombinant baculovirus. The E2 protein was purified as described
by Seo et al. (37). E1 protein was purified by a modified
procedure of that described by Bonne-Andrea et al. (4).
Infected cells were thawed in 5 volumes of hypotonic buffer (20 mM
Tris-HCl [pH 8.0], 5 mM KCl, 1 mM MgCl2, 1 mM
dithiothreitol [DTT], 0.1 mM phenylmethylsulfonyl fluoride,
proteinase inhibitors [0.05 mM EGTA, 20 µg of aprotinin per liter,
20 µg of leupeptin per liter, 10 µg of antipain per liter]) and
lysed by Dounce homogenization with 20 strokes with a type B pestle.
The lysate was centrifuged for 15 min at 10,000 rpm in a Beckman SS-34
rotor, and the pelleted nuclei washed with 20 mM Tris-HCl (pH
8.0)-10% (wt/vol) sucrose-1 mM EDTA. Nuclei were resuspended in NR
buffer (20 mM Tris-HCl [pH 8.0], 50 mM MgSO4, 500 mM
NaCl, 0.5% [vol/vol] Nonidet P-40, 5 mM DTT, 0.1 mM
phenylmethylsulfonyl fluoride, proteinase inhibitors) and incubated on
ice for 30 min. The nuclei were pelleted as above, and the supernatant
was mixed with glutathione-Sepharose beads (previously equilibrated in
NR buffer) and nutated for 1 h at 4°C. The beads were washed
with 50 bead volumes of NR buffer: three washes with NR buffer
containing 1 M NaCl, and three washes with XPa cleavage buffer (50 mM
Tris-HCl [pH 8.0], 10 mM MgSO4, 100 mM NaCl, 10%
[vol/vol] glycerol, 1 mM CaCl2, 5 mM DTT). E1 was then
cleaved from the beads by incubation with biotinylated XPa (Boehringer
Mannheim) for 4 h at 4°C. The beads were briefly centrifuged,
and the supernatant containing the liberated E1 was removed.
Streptavidin beads (Boehringer Mannheim) were added to remove the
biotinylated XPa.
BPV constructs.
The BPV DNA containing the mutated origin
was generated by PCR with the Stratagene Quick Change kit. The
following oligonucleotides were used for mutagenesis (mutated bases
underlined): BPV origin-containing DNA fragments.
The BPV
origin-containing DNA fragments (~120 bp) were generated by PCR
amplification of pKSO (45), pXS Electrophoretic mobility shift assays.
To prepare E1-origin
and E1-E2-origin complexes, reaction mixtures (30 µl) containing 25 mM potassium phosphate (pH 7.5), 0.1 M potassium glutamate, 7 mM
MgCl2, 1 mM EDTA, 0.5 mM DTT, 4 mM ATP, 10% glycerol, 300 ng of pBluescript KS+ (as a nonspecific competitor), 200 fmol of the
origin-containing fragment, and E1 alone or E1 and E2 (as indicated)
were incubated for 15 min at 37°C. Glutaraldehyde (final
concentration, 0.1%) was added, and the reaction mixtures were
incubated for an additional 5 min. The resulting complexes were
separated by electrophoresis through a native 5% polyacrylamide gel
(acrylamide/bisacrylamide ratio, 29:1) and visualized by
autoradiography.
Interference assays.
Chemical modification of the
origin-containing DNA fragment was performed as described previously
(35). After the separation of the protein-DNA complexes by a
gel retardation assay (see above), gel slices containing the complexes
were excised, crushed, and soaked overnight in gel elution buffer (0.5 M ammonium acetate, 0.1% sodium dodecyl sulfate, 1 mM EDTA). The
eluted DNA was precipitated with ethanol and then resuspended in TE (10 mM Tris-HCl [pH 8.0], 1 mM EDTA). The DNA was extracted with
phenol-chloroform (1:1, vol/vol) and precipitated with ethanol. The
modified DNA was then cleaved as described previously (35).
Assignation of interfering or stimulatory modifications was determined
by careful comparison of the results of multiple independent
interference experiments.
Transient-replication assays.
Transient-replication assays
were performed as described by Mendoza et al. (28). The BPV
genomic DNA was released from the vector by digestion with
BamHI. Linearized DNA was purified by phenol-chloroform
(1:1, vol/vol) extraction followed by ethanol precipitation and
resuspension in TE. C127 cells growing in the log phase were
trypsinized, pelleted, washed, and resuspended in Dulbecco's modified
Eagle's medium (DMEM)-5 mM
N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES) (pH 7.2) at a concentration of 2 × 107
cells/ml. The cell suspension (0.25 ml) was mixed with 2 µg of input
DNA, 0.5 µg of pSS3 linearized with SalI (containing the wild-type viral DNA not released from the vector, to serve as an
internal standard), and 50 µg of sheared salmon sperm DNA and transferred to a electroporation cuvette (0.4-cm gap; Bio-Rad). Electroporation was performed at 270 V and 960 µF in a Bio-Rad gene
pulser. The cell material was then transferred to 10 ml of DMEM
containing 10% fetal bovine serum, and 1 ml was added to each 10-cm
plate containing 9 ml of DMEM with 10% fetal bovine serum. For each
time point, low-molecular-weight DNA was extracted from two plates of
cells by the method of Hirt (15). The isolated viral DNA was
restricted with MunI to linearize the viral genome and
DpnI to remove unreplicated DNA. DNA was detected by
Southern blot analysis with nick-translated pSS3 as a probe. The
replication activity in vivo was quantitated by excision of the bands
and counting in a scintillation counter.
Key origin contacts used by E1 and E2 identified by interference
assays.
Three distinct complexes can be detected when the BPV E1
protein alone or E1 and E2 proteins are incubated with DNA fragments containing the wild-type origin (the central region flanked by BS11 and
BS12) in an electrophoretic mobility shift assay (Fig. 1). In the presence of E1 alone, a
relatively slow-migrating C2 complex is detected (lane 1) (23,
34). When both E1 and E2 are added, a novel complex (that we
define as C3) that migrates slightly more slowly than C2 is generated,
in addition to the quickly migrating C1 complex (lane 2 [23; see also references 32 and
33]).
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Distinct Roles of Two Binding Sites for the Bovine
Papillomavirus (BPV) E2 Transactivator on BPV DNA Replication
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
5' direction (36, 46).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
BS12,
5'-GTTGTTAACAATAATCACGTTCTCACGTACTTTTCAAGCGGGAAAAAATAGCC (top primer) and
5'-GGCTATTTTTTCCCGCTTGAAAAGTACGTGAGAACGTGATTATTGTTAACAAC (bottom primer); and
BS11,
5'-GCAGCATTATATTTTAAGCTCGTTCAAACGTACAAGTAAAGACTATGTATTTTTTCC (top primer) and 5'
GGAAAAAATACATAGTCTTTACTTGTACGTTTGAACGAGCTTAAAATATAATGCTGC (bottom primer). The top strand is defined as that containing the
run of T's between BPV positions 7925 and 7930. The template plasmid
used to prepare the
BS12 and
BS11 mutants was pXS (in which the
BPV XbaI-SmaI fragment from nucleotides [nt]
6132 to 945, was inserted into a vector derived from pML-1
[21]). The template plasmid for the
BS12
BS11
double mutant was pXS
BS12. Mutations were verified by sequencing. To
generate the full-length viral DNA containing the mutated origins, the
pXS plasmids were digested with MluI and MunI and
the origin-containing fragment was inserted into the
MluI-MunI site of pSS3 (28).
BS12, or pXS
BS11 (to
prepare the wild-type,
BS12, or
BS11 origin, respectively). One
of the two origin-flanking primers was 5'-32P labeled with
T4 polynucleotide kinase (Boehringer Mannheim) to a specific activity
of approximately 1 × 106 to 2 × 106
cpm/pmol.
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

View larger version (29K):
[in a new window]
FIG. 1.
Complexes formed on the wild-type BPV origin by E1 and
E2. E1 alone (100 ng) (lane 1) or E1 (100 ng) plus E2 (60 ng) (lane 2)
were incubated for 15 min at 37°C with a 32P-labeled DNA
fragment containing the wild-type origin. The complexes were
cross-linked by treatment with glutaraldehyde, separated by
electrophoresis through a native 5% polyacrylamide gel, and visualized
by autoradiography. The locations of the C1, C2, and C3 complexes are
indicated.
Differential requirements for E2 binding in the C1 and C3 complexes. Key protein contacts with purines and pyrimidines were examined by the "missing-contact" approach of Brunelle and Schlief (6). Purine contacts were determined by using a DNA fragment modified with formic acid, leading to partial depurination (Fig. 2) (6, 27). Conversely, protein contacts with pyrimidines were examined by using a DNA fragment treated with hydrazine, a reagent that causes destruction of the pyrimidine base (Fig. 3) (6, 27). Each reagent leaves the sugar-phosphate backbone intact. The effect of each modification was examined on a DNA fragment that was 5'-32P labeled on either the top (Fig. 2A and 3A) or bottom (Fig. 2B and 3B) strand.
|
|
Overlap of AT-region phosphate contacts with site of primary origin distortion. The contacts made by E1 and E2 to the sugar-phosphate backbone were examined (Fig. 4). The DNA substrate was ethylated at phosphate positions with N-nitroso-N-ethylurea, generating phosphotriesters (38). Similar to that observed for the missing-base assays, E1 interaction with the backbone of the dyad region was critical for C2 complex formation (Fig. 4, lanes 3; compiled in Fig. 5C).
|
|
Each E2-binding site stimulates formation of a different
complex.
Our data suggest that, contrary to published data
(40), both BS11 and BS12 play key roles during the
initiation of BPV DNA replication. We therefore examined complex
formation on BPV origins in which one of the two E2-binding sites was
mutated to prevent E2 binding (Fig. 6).
Complex formation was tested by a gel retardation assay in the presence
of low levels (6.25 to 25 ng) of E1 to more closely mimic the
expression levels in infected cells. Binding to the wild-type origin,
as well as to mutant origins lacking BS11 (
BS11) or BS12 (
BS12),
was tested. In the absence of E2, E1 formed the C2 complex on the
wild-type (lanes 1 to 3) and
BS11 (lanes 7 to 9) origins, but only
at the highest levels of E1 (25 ng). In contrast, C2 formed to a lower
degree on the
BS12 origin at 25 ng of E1 (lanes 4 to 6). This result
again indicates that sequences within the BS12 element stabilize E1
binding to the BPV origin.
|
BS12 (lanes 13 to 15), even using 10-fold-higher levels of E1
or E2 (data not shown). In constrast, C3 complex formation was observed
on
BS12 using 25 ng of E1. On
BS11, C1 complex formation was seen
at a level similar to that on the wild-type origin, while C3 formation
was not observed. In summary, BS12 was required for C1 complex
formation, BS11 was necessary for formation of the C3 complex, and both
BS11 and BS12 were required for maximal stimulation of C3 complex
formation.
Both E2-binding sites are required for wild-type levels of
replication in vivo.
The requirement for the E2-binding sites in
viral DNA replication was tested in vivo using a transient replication
assay. To reproduce the levels of E1 and E2 occurring during viral
infection, mutant origins were constructed in the context of viral DNA.
A plasmid containing the BPV genome (pSS3 [28];
designated the wild type) was mutated to remove one or both of the
E2-binding sites from the origin (designated
BS11,
BS12, and
BS11
BS12, lacking BS11, BS12, and both elements, respectively).
As a negative control, an origin was used with a 15-bp insertion in the
dyad symmetry element (designated LI 15C), previously shown to
inactivate the viral origin (28). Each of these constructs
was linearized with BamHI to liberate the viral genome from
the vector, and the linearized DNA was transfected into C127 cells by
electroporation. The test plasmids were cotransfected with wild-type
viral DNA, not released from the vector, which served as an internal
control. After 72 and 96 h, the viral DNA was isolated and
linearized and the unreplicated DNA was destroyed by digestion with
DpnI.
BS11
BS12 and LI 15C viral constructs failed to replicate
(Fig. 7). At each time point, the
BS11
and
BS12 origins were defective compared to the wild type, since
BS11 and
BS12 replicated to 30 and 20% of the wild-type level,
respectively. Similar effects on replication were observed when these
experiments were repeated by varying the ratio of the
wild-type-to-mutant origin template (1:10 and 1:1; data not shown),
indicating that the inhibition is not a result of altered expression of
E1 and E2. The presence of both E2-binding sites therefore resulted in
a synergistic response of viral DNA replication. The inability of the
mutant origins to replicate at wild-type levels indicates that both
flanking E2-binding sites are important for BPV replication under
physiological levels of E1 and E2 expression.
|
| |
DISCUSSION |
|---|
|
|
|---|
Our data indicate that the BPV E2 transactivator enables viral replication by facilitating discrete steps during formation of the viral initiation complex. These data lead to a model in which the initiation complex is formed in a pathway that entails the sequential interaction of E2 with two binding sites flanking the central origin region, each stabilizing a distinct E1-origin complex. In the first step, E2 binding to the BS12 element is required to form a replication-incompetent complex which contains a low oligomeric form of E1 bound to the dyad symmetry element within the central origin region. Additional E1 monomers bind and extend this complex outward, forming a replication-active species, in a step in which E2 binding to BS11 becomes paramount and E2 bound to BS12 is displaced.
A previous study concluded that only one of the two E2-binding sites (BS12) flanking the central origin region was required to support efficient viral DNA replication in vivo (40). In contrast, we found that both BS11 and BS12 play distinct roles of similar importance, indicated by the comparable reduction of transient replication caused by mutation of either of these two sites. The likely cause for this difference is that Ustav et al. (40) overexpressed E1 and E2 while our replication assays expressed E1 and E2 in the context of the viral genome. Since E1 is detected at extremely low levels in infected cells (31, 39), our data suggest that E1 overexpression inadequately reproduces replication conditions during infection.
The initiation of viral replication appears to involve the formation of the C1 recognition complex, although this complex per se is not active in replication. Stenlund and colleagues have made compelling arguments that a similar fast-migrating complex is critical by virtue of increasing the specificity of E1 for origin sequences (32, 33). Indeed we found that at low levels of E1, the C1 complex recruits E1 more effectively to the origin than does the C3 complex. These workers also found that a single E2-binding site engineered at different positions within the dyad-proximal flank of the origin can support complex formation by E1 and E2 (32). Using origins that contain BS11 but lack BS12, we were unable to observe a rapidly migrating complex similar to C1, even at very high levels of E1 or E2 (data not shown). In that the E1 recognition element has general twofold symmetry (see, e.g., reference 16), it seems unlikely that C1-like complexes can form only by using an E2-binding site located on the BS12 side of the origin. Two non-mutually exclusive causes appear more reasonable. First, the distance between E2 bound to BS11 and E1 bound to the dyad element may be too great to allow stable complex formation. Second, since the transition of C1 to C3 correlates with an extension of the E1 footprint into the AT-rich region (13), physical interaction between E2 binding to BS11 and the adjacent E1 may greatly favor the formation of C3 compared to a complex containing E1 bound only to the dyad region.
The C1 and C3 complexes are distinctly different by various criteria. Most obvious is the relative importance of the BS11 and BS12 elements for C3 and C1 complex formation, respectively, but other notable differences exist. Formation of C3 requires a larger number of phosphate contacts, particularly in the dyad region, supporting the hypothesis that E1 is in a higher oligomeric state in the C3 (and C2) complex compared to that in C1 and similar complexes (23, 33). C3 formation also utilizes contacts with purines in the AT-rich region (this work) and, from our previous DNA-probing analysis of the C3 complex in solution (13), results in protection of the minimal core origin sequence from nuclease attack. In contrast, E1 and E2 in the C1 complex had significant interactions only with the right half of the origin including the dyad region. Finally, our prior footprinting study of the C3 and C1 complexes in solution indicated that the C3 complex was competent to induce distortion in the origin structure while C1 was lacking in this ability (13).
In contrast to the dissimilarity between C3 and C1, the overall disposition of E1 in the C2 and C3 complexes appears similar. The pattern of base and phosphate interference for the C2 and C3 complexes is alike (Fig. 5), as is the ability of these complexes to distort origin structure (13). The mobility of the C3 complex by a gel retardation assay was only slightly reduced compared to that of C2, reflective of the additional molecular weight provided by E2 binding to BS11, indicating that the E1 oligomeric state in the two complexes is similar. Because of the great similarity of the C2 and C3 complexes, our data argues that C3, like C2, is replication competent. It is clear that E2 binding to BS11 significantly stabilizes C3 at low E1 levels (Fig. 6), indicating that the main role of E2 binding to BS11 is to stabilize this replication-active complex. The low expression levels of E1 in infected cells lead us to suggest that the normal replication-active complex in BPV-infected cells is C3 rather than C2.
Various data indicate that the C3 complex forms by using a favored pathway with C1 as an intermediate. First, our mobility shift assays show that formation of the C3 complex is stimulated by the presence of BS12, which is critical for C1 formation. Conversely, the BS11 element does not stimulate formation of the C1 complex. Second, modification of BS12 phosphates which are important for C1 complex formation also inhibits C3 formation, although to a lesser degree. This observation would be expected for a pathway in which C1 precedes C3. Third, modifications within BS11 that prevent C3 complex formation were found to stimulate the formation of C1. In other words, preventing E2 from binding to BS11 led to an increase in C1 complex formation. This result would also be predicted by a model in which C1 converts to C3. These observations strongly support the hypothesis that the C1 complex initially forms and then is transformed into the C3 complex.
We note, however, that if C1 complex formation were essential for the subsequent formation of the final initiation complex, BS12 modification would be expected to have similar effects on C1 and C3 complex formation, a result we did not observe. We therefore suggest that replication-active complexes can form independent of C1, although this pathway is conditional on the stabilization of E1 binding to the origin by the E2-BS11 complex. Similarly, we can conclude that BS11 is not essential for replication if E2 binding to BS12 is possible. Thus, formation of an active viral replication complex can occur by multiple pathways. Because the viral DNA lacking either BS12 or BS11 replicates to levels 20 to 30% of that in the wild type, the pathway involving both the C1 and C3 complexes appears to be favored.
We found that removal of nearly any base in the dyad element is similarly deleterious for C1 and C3 complex formation. This is particularly surprising with respect to C1, since the phosphate contacts fall predominantly on one helical face (data not shown), a result observed previously for a C1-like complex (33). We find it doubtful that E1 could form important contacts with nearly every dyad base yet use primarily one helical face of the DNA for binding. A more probable explanation derives from observations that DNA molecules containing an abasic residue have structural perturbations (see, e.g., reference 9). Loss of bases in the origin would therefore be expected to alter both the conformation and dynamic properties of the DNA, resulting in destabilization of the E1-origin complex.
We previously observed that E1 binding to the origin induced ATP-dependent structural distortions within the AT-rich region and, to a lesser degree, within the dyad element and BS12 (Fig. 5B) (13). In the present study, we found six phosphates and three bases in the nt 7930 region whose modification inhibited C3 complex formation. The base contacts were important for both C2 and C3 formation, showing that E1 uses limited sequence recognition of the AT-rich region. The nt 7930 region base and phosphate contacts, which fall on one helical face of the DNA, overlap the primary site of DNA distortion (Fig. 5B) (13), suggesting that these contacts are used to induce the structural transitions. These phosphate contacts are apparently more critical for C3 formation because their modification did not noticeably disrupt C2 complex formation. E2 was shown previously to lower the amount of E1 required to distort this region (13). These data suggest that E2 bound to BS11 causes E1 to more closely approach the DNA in the nt 7930 region. This effect may be a more general property of E1-E2 interactions, because ethylation of top-strand phosphates at nt 12 to 15 (adjacent to BS12) had a greater effect on C1 formation than on C2 formation. The ability of E2 to increase the interfering properties of phosphate ethylation may be due to an E2-induced conformational change within E1 that alters the interaction of E1 with DNA. Since E2 is known to bend DNA fragments (14), a related effect may be that E2-mediated DNA bending at each E2-binding site both heightens the deleterious effects of phosphate modification between the dyad and each E2 binding site and facilitates the E1-mediated DNA distortion in the nt 7930 region.
Our previous DNase I footprinting analysis of the wild-type viral origin showed that in the presence of E2, an increase in the concentration of E1 caused an extension of protection into the region between the dyad element and BS11 (13). The boundary of the footprint at low E1 concentrations (corresponding to the C1 complex [Fig. 5A]) overlapped the region of primary structural distortion. From this data, we suggested that increases in E1 concentration caused an additional lobe of E1 to bind adjacent to that E1 situated over the dyad element (13). Since we observed few key phosphate contacts in the AT-rich region other than those in the nt 7930 region, our results do not support the suggestion that two independent lobes of E1 bind to the dyad and AT-rich regions. Instead, they indicate that E1 binding to the AT-rich region is an extension of the E1 bound over the dyad element. This larger E1 structure would therefore be responsible for the induction of structural changes within the viral origin.
Clues to the mechanism of formation of the C3 complex by E1 and E2 can likely be obtained from comparison with the SV40 T antigen. E1 is homologous to T antigen, particularly in their C-terminal regions (8), which, for T antigen, contain the ATPase and other elements critical for DNA helicase activity (12). The two proteins have similar activities including the ability to bind and unwind the origin in the presence of a single-stranded-DNA-binding protein (10, 36, 44, 46). Each protein can bind the origin in both low and high oligomeric forms by using a central palindromic structure (23, 25, 26, 32, 33). In the presence of ATP, structural changes are induced on each side of the central palindrome (5, 13). Analysis of the T-antigen-SV40 origin complex by scanning transmission electron microscopy and DNA probing has shown that T antigen is bound as a double hexamer, with twofold symmetry around the central palindrome (26, 35).
The similar characteristics of E1 and T antigen, combined with the results of previous binding studies, lead to the following model of E1 binding to the BPV origin (Fig. 8). E1 initially binds the origin in a low oligomeric state, using symmetrical contacts with the dyad symmetry element, and is stabilized by E2 bound to BS12 (13, 23, 32, 33) (see above). The binding of additional E1 monomers enlarges the complex, both toward the proximal edge of the BS11 element and 10 bp beyond the distal edge of the BS12 element, as observed in the DNase I footprint of the C2 complex (Fig. 5C). A key feature of this model is that the twofold symmetry around the central palindrome is maintained. The rightward extension of the complex displaces the E2 bound to the BS12 element but is stabilized by (and stabilizes) E2 binding to BS11. Recent data by Berg and Stenlund (2) has shown that E2 has two distinct domains that can interact with E1, the DNA-binding domain and the transactivating domain, and our data indicates that each domain may be differentially used in the C1 complex and the C3 complex. In the presence of ATP, this higher oligomeric C3 complex induces structural transitions, primarily within the nt 7930 region, but also to significant levels within BS12. Similar to T antigen, the final complex would have two helicase entities, one bound to the left half of the dyad element and the AT-rich region and the other bound to the right half of the dyad element and the BS12 region. Since hRPA can denature DNA under conditions supporting DNA replication (18), the interaction of hRPA with the distorted DNA region(s) leads to origin denaturation and unwinding of the DNA by the DNA helicase activity of E1.
|
Although transcriptional transactivators have been found to modulate DNA replication by a diversity of mechanisms, our data indicates that E2 is perhaps unique in its ability to use multiple binding sites to sequentially activate viral replication. Other papillomaviruses have multiple E2-binding sites in origin-proximal regions, and it would not be surprising to find the differential usage by E2 of these sites during the initiation of replication.
| |
ACKNOWLEDGMENTS |
|---|
We thank Philippe Clertant for his generous gift of the baculovirus GST-E1 construct and Mike Botchan for his kind gift of the pSS3 and BPV LI 15C plasmids. We thank Cristina Iftode, Natalia Smelkova, Jennifer Garner, and Yaron Daniely for constructive comments during the course of this project and for critical readings of the manuscript.
This research was supported by NIH grant CA62198, Kaplan Cancer Center Developmental Funding, and a Kaplan Cancer Center Support Core Grant (NCI P30CA16087).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biochemistry and Kaplan Comprehensive Cancer Center, New York University Medical Center, 550 First Ave., New York, NY 10016. Phone: (212) 263-8453. Fax: (212) 263-8166. E-mail: borowj01{at}mcrcr.med.nyu.edu.
Present address: Department of Pathology, University of Texas
Southwestern Medical Center, Dallas, TX 75235.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Benson, J. D., and P. M. Howley. 1995. Amino-terminal domains of the bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation. J. Virol. 69:4364-4372[Abstract]. |
| 2. | Berg, M., and A. Stenlund. 1997. Functional interactions between papillomavirus E1 and E2 proteins. J. Virol. 71:3853-3863[Abstract]. |
| 3. |
Blitz, I. L., and L. A. Laimins.
1991.
The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro.
J. Virol.
65:649-656 |
| 4. |
Bonne-Andrea, C.,
S. Santucci,
P. Clertant, and F. Tillier.
1995.
Bovine papillomavirus E1 protein binds specifically DNA polymerase but not replication protein A.
J. Virol.
69:2341-2350[Abstract].
|
| 5. | Borowiec, J. A., and J. Hurwitz. 1988. Localized melting and structural changes in the SV40 origin of DNA replication induced by T antigen. EMBO J. 7:3149-3158[Medline]. |
| 6. |
Brunelle, A., and R. F. Schleif.
1987.
Missing contact probing of DNA-protein interactions.
Proc. Natl. Acad. Sci. USA
84:6673-6676 |
| 7. | Cheng, L., and T. J. Kelly. 1989. Transcriptional activator nuclear factor I stimulates the replication of SV40 minichromosomes in vivo and in vitro. Cell 59:541-551[Medline]. |
| 8. | Clertant, P., and I. Seif. 1984. A common function for polyoma virus large-T and papillomavirus E1 proteins? Nature 311:276-279[Medline]. |
| 9. | Coppel, Y., N. Berthet, C. Coulombeau, C. Coulombeau, J. Garcia, and J. Lhomme. 1997. Solution conformation of an abasic DNA undecamer duplex d(CGCACXCACGC) x d(GCGTGTGTGCG): the unpaired thymine stacks inside the helix. Biochemistry 36:4817-4830[Medline]. |
| 10. |
Dean, F. B.,
P. Bullock,
Y. Murakami,
C. R. Wobbe,
L. Weissbach, and J. Hurwitz.
1987.
Simian virus 40 (SV40) DNA replication: SV40 large T antigen unwinds DNA containing the SV40 origin of replication.
Proc. Natl. Acad. Sci. USA
84:16-20 |
| 11. |
Diffley, J. F., and B. Stillman.
1988.
Purification of a yeast protein that binds to origins of DNA replication and a transcriptional silencer.
Proc. Natl. Acad. Sci. USA
85:2120-2124 |
| 12. | Fanning, E., and R. Knippers. 1992. Structure and function of simian virus 40 large tumor antigen. Annu. Rev. Biochem. 61:55-85[Medline]. |
| 13. |
Gillette, T. G.,
M. Lusky, and J. A. Borowiec.
1994.
Induction of structural changes in the bovine papillomavirus type 1 origin of DNA replication by the viral E1 and E2 proteins.
Proc. Natl. Acad. Sci. USA
91:8846-8850 |
| 14. | Hegde, R. S., S. R. Grossman, L. A. Laimins, and P. B. Sigler. 1992. Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359:505-512[Medline]. |
| 15. | Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369[Medline]. |
| 16. |
Holt, S. E.,
G. Schuller, and V. G. Wilson.
1994.
DNA binding specificity of the bovine papillomavirus E1 protein is determined by sequences contained within an 18-base-pair inverted element at the origin of replication.
J. Virol.
68:1094-1102 |
| 17. | Holt, S. E., and V. G. Wilson. 1995. Mutational analysis of the 18-base-pair inverted repeat element at the bovine papillomavirus origin of replication: identification of critical sequences for E1 binding and in vivo replication. J. Virol. 69:6525-6532[Abstract]. |
| 18. | Iftode, C., and J. A. Borowiec. 1997. Denaturation of the simian virus 40 origin of replication mediated by human replication protein A. Mol. Cell. Biol. 17:3876-3883[Abstract]. |
| 19. | Jones, K. A., J. T. Kadonaga, P. J. Rosenfeld, T. J. Kelly, and R. Tjian. 1987. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48:79-89[Medline]. |
| 20. | Li, R., and M. Botchan. 1993. The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication. Cell 73:1207-1221[Medline]. |
| 21. |
Lusky, M., and M. R. Botchan.
1986.
Transient replication of bovine papilloma virus type 1 plasmids: cis and trans requirements.
Proc. Natl. Acad. Sci. USA
83:3609-3613 |
| 22. |
Lusky, M., and E. Fontane.
1991.
Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1.
Proc. Natl. Acad. Sci. USA
88:6363-6367 |
| 23. |
Lusky, M.,
J. Hurwitz, and Y.-S. Seo.
1994.
The bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric E1-replication origin complex.
Proc. Natl. Acad. Sci. USA
91:8895-8899 |
| 24. |
Lusky, M.,
J. Hurwitz, and Y.-S. Seo.
1993.
Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site.
J. Biol. Chem.
268:15795-15803 |
| 25. |
Mastrangelo, I. A.,
P. V. Hough,
V. G. Wilson,
J. S. Wall,
J. F. Hainfeld, and P. Tegtmeyer.
1985.
Monomers through trimers of large tumor antigen bind in region I and monomers through tetramers bind in region II of simian virus 40 origin of replication DNA as stable structures in solution.
Proc. Natl. Acad. Sci. USA
82:3626-3630 |
| 26. | Mastrangelo, I. A., P. V. C. Hough, J. S. Wall, M. Dodson, F. B. Dean, and J. Hurwitz. 1989. ATP-dependent assembly of double hexamers of SV40 T antigen at the viral origin of DNA replication. Nature 338:658-662[Medline]. |
| 27. | Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499-560[Medline]. |
| 28. | Mendoza, R., L. Gandhi, and M. R. Botchan. 1995. E1 recognition sequences in the bovine papillomavirus type 1 origin of DNA replication: interaction between half sites of the inverted repeats. J. Virol. 69:3789-3798[Abstract]. |
| 29. |
Mohr, I. J.,
R. Clark,
S. Sun,
E. J. Androphy,
P. MacPherson, and M. R. Botchan.
1990.
Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator.
Science
250:1694-1699 |
| 30. |
O'Neill, E. A.,
C. Fletcher,
C. R. Burrow,
N. Heintz,
R. G. Roeder, and T. J. Kelly.
1988.
Transcription factor OTF-1 is functionally identical to the DNA replication factor NF-III.
Science
241:1210-1213 |
| 31. |
Santucci, S.,
E. Androphy,
C. Bonne-Andréa, and P. Clertant.
1990.
Proteins encoded by the bovine papillomavirus E1 open reading frame: expression in heterologous systems and in virally transformed cells.
J. Virol.
64:6027-6033 |
| 32. | Sedman, J., and A. Stenlund. 1995. Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. EMBO J. 14:6218-6228[Medline]. |
| 33. | Sedman, J., and A. Stenlund. 1996. The initiator protein E1 binds to the bovine papillomavirus origin of replication as a trimeric ring-like structure. EMBO J. 15:5085-5092[Medline]. |
| 34. | Sedman, T., J. Sedman, and A. Stenlund. 1997. Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus. J. Virol. 71:2887-2896[Abstract]. |
| 35. | SenGupta, D. J., and J. A. Borowiec. 1994. Strand and face: the topography of interactions between the SV40 origin of replication and T antigen during the initiation of replication. EMBO J. 13:982-992[Medline]. |
| 36. |
Seo, Y.-S.,
F. Müller,
M. Lusky, and J. Hurwitz.
1993.
Bovine papilloma viral (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication.
Proc. Natl. Acad. Sci. USA
90:702-706 |
| 37. |
Seo, Y.-S.,
F. Müller,
M. Lusky,
E. Gibbs,
H. Y. Kim,
B. Phillips, and J. Hurwitz.
1993.
Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin.
Proc. Natl. Acad. Sci. USA
90:2865-2869 |
| 38. | Singer, B., and H. Fraenkel-Conrat. 1975. The specificity of different classes of ethylating agents toward various sites in RNA. Biochemistry 14:772-782[Medline]. |
| 39. |
Sun, S.,
L. Thorner,
M. Lentz,
P. MacPherson, and M. Botchan.
1990.
Identification of a 68-kilodalton nuclear ATP-binding phosphoprotein encoded by bovine papillomavirus type 1.
J. Virol.
64:5093-5105 |
| 40. |
Ustav, E.,
M. Ustav,
P. Szymanski, and A. Stenlund.
1993.
The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator.
Proc. Natl. Acad. Sci. USA
90:898-902 |
| 41. | Ustav, M., and A. Stenlund. 1991. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10:449-457[Medline]. |
| 42. | Ustav, M., E. Ustav, P. Szymanski, and A. Stenlund. 1991. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 10:4321-4329[Medline]. |
| 43. | van der Vliet, P. C. 1996. Roles of transcription factors in DNA replication, p. 87-118. In M. L. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 44. |
Wold, M. S.,
J. J. Li, and T. J. Kelly.
1987.
Initiation of simian virus 40 DNA replication in vitro: Large-tumor-antigen- and origin-dependent unwinding of the template.
Proc. Natl. Acad. Sci. USA
84:3643-3647 |
| 45. | Yang, L., R. Li, I. J. Mohr, R. Clark, and M. R. Botchan. 1991. Activation of BPV-1 replication in vitro by the transcription factor E2. Nature 353:628-632[Medline]. |
| 46. |
Yang, L.,
I. Mohr,
E. Fouts,
D. A. Lim,
M. Nohaile, and M. Botchan.
1993.
The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase.
Proc. Natl. Acad. Sci. USA
90:5086-5090 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»